NCT06096571View on ClinicalTrials.gov

Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

December 30, 2024

Conditions

Viral Infection COVID-19

Interventions

DRUG

Aterixen

A single dose of R or T drug in each of 2 periods of the study in fasted conditions

Trial Locations (1)

196143

"Limited Liability Company Research Center Eco-Safety", Saint Petersburg

All Listed Sponsors

lead

Valenta Pharm JSC

INDUSTRY

NCT06096571 - Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers | Biotech Hunter | Biotech Hunter